Abstract
In this mini review we discuss the interactions of polyaromatic hydrocarbons (PAHs) with graphene and the experimental approaches developed so far to create novel graphene/PAH hybrids and composite systems. The utilization of these systems in electrical, biomedical and polymer-reinforcement applications is described while special emphasis is given to environmental remediation issues.
Keywords: Graphene, graphene oxide, polycyclic aromatic hydrocarbons, non-covalent interactions, nanocomposites, polymer reinforcement, environmental remediation.
Graphical Abstract
Current Organic Chemistry
Title:Non-covalent Interactions of Graphene with Polycyclic Aromatic Hydrocarbons
Volume: 19 Issue: 18
Author(s): Panagiota Zygouri, Georgia Potsi, Eleftherios Mouzourakis, Konstantinos Spyrou, Dimitrios Gournis and Petra Rudolf
Affiliation:
Keywords: Graphene, graphene oxide, polycyclic aromatic hydrocarbons, non-covalent interactions, nanocomposites, polymer reinforcement, environmental remediation.
Abstract: In this mini review we discuss the interactions of polyaromatic hydrocarbons (PAHs) with graphene and the experimental approaches developed so far to create novel graphene/PAH hybrids and composite systems. The utilization of these systems in electrical, biomedical and polymer-reinforcement applications is described while special emphasis is given to environmental remediation issues.
Export Options
About this article
Cite this article as:
Zygouri Panagiota, Potsi Georgia, Mouzourakis Eleftherios, Spyrou Konstantinos, Gournis Dimitrios and Rudolf Petra, Non-covalent Interactions of Graphene with Polycyclic Aromatic Hydrocarbons, Current Organic Chemistry 2015; 19 (18) . https://dx.doi.org/10.2174/1385272819666150526003634
DOI https://dx.doi.org/10.2174/1385272819666150526003634 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
SCF E3 Ubiquitin Ligases as Anticancer Targets
Current Cancer Drug Targets Withdrawal Notice: The Recent Advancement in the Field of Super Paramagnetic Iron Oxide Nanoparticles (SPIONs) for Aiming Breast Cancer
Current Drug Metabolism Patent Selections
Recent Patents on DNA & Gene Sequences Pharmacogenetics of Target Genes Across Doxorubicin Disposition Pathway: A Review
Current Drug Metabolism Osteonecrosis of the Jaw and Angiogenesis inhibitors: A Revival of a Rare but Serous Side Effect
Current Medicinal Chemistry Development of Anti-HIV Agents Targeting Dynamic Supramolecular Mechanism: Entry and Fusion Inhibitors Based on CXCR4/CCR5 Antagonists and gp41-C34-Remodeling Peptides
Current HIV Research Resveratrol and Its Analogues: Promising Antitumor Agents
Anti-Cancer Agents in Medicinal Chemistry RNA Interference-Mediated Validation of Survivin and Apollon/BRUCE as New Therapeutic Targets for Cancer Therapy
Current Topics in Medicinal Chemistry Synthesis, Characterization and Evaluation of Cytotoxicity of New Aminophosphonic Acid Diesters in Human Leukemia Cells
Letters in Drug Design & Discovery Roles of Chemokine CXCL12 and its Receptors in Ischemic Stroke
Current Drug Targets Nonstandard Drugs and Feasible New Interventions for Autoimmune Hepatitis: Part I
Inflammation & Allergy - Drug Targets (Discontinued) Viruses in Semen and Male Genital Tissues - Consequences for the Reproductive System and Therapeutic Perspectives
Current Pharmaceutical Design Biodistribution and Dosimetry of 177Lu-tetulomab, a New Radioimmunoconjugate for Treatment of Non-Hodgkin Lymphoma
Current Radiopharmaceuticals Histone Deacetylases: Anti-Angiogenic Targets in Cancer Therapy
Current Cancer Drug Targets Discovery of 4-Aryl-4H-Chromenes as Potent Apoptosis Inducers Using a Cell- and Caspase-Based Anti-Cancer Screening Apoptosis Program (ASAP): SAR Studies and the Identification of Novel Vascular Disrupting Agents
Anti-Cancer Agents in Medicinal Chemistry Moving Beyond VEGF for Anti-angiogenesis Strategies in Gynecologic Cancer
Current Pharmaceutical Design From the Table to the Bedside: Can Food-Derived Sulforaphane be used as a Novel Agent to Treat Leukemia?
Current Cancer Drug Targets Histone Deacetylase Inhibitors In Inflammatory Disease
Current Topics in Medicinal Chemistry Circulating Tumor Cells: A New Window for Diagnosis and Evaluation of Cancer
Anti-Cancer Agents in Medicinal Chemistry Morpholine Based Diazenyl Chalcones: Synthesis, Antimicrobial Screening and Cytotoxicity Study
Anti-Cancer Agents in Medicinal Chemistry